1st QUARTER 2022
Reporting
On April 21, 2022 Evonik has published preliminary financial data for the 1st quarter 2022.
The regular quarterly report followed on May 6, 2022. You can access further information here.
- Adj. EBITDA of €735 m (+25% yoy) clearly above expectations (consensus of €652 m)
- Drivers of strong Q1 performance: Nutrition & Care with 9th quarter of resilient yoy growth; Performance Materials working as natural hedge against higher oil prices
- Positive effect from own price increases further ramping up (>€750 m after ~€600 m in Q4 2021), again overcompensating variable cost increases on Group level
- FCF (€133 m) burdened by further outflow for NWC as a result of continued cost inflation and higher safety stock levels to prepare for potential supply chain challenges
- Outlook of adj. EBITDA between €2.5 and 2.6 bn confirmed
Reporting 1st Quarter 2022
|
Document
|
Link/PDF |
|
Analyst & Investor Factsheet |
|
|
Presentation Q1 2022 results |
|
|
Detailed overview of key financial data (Evonik Financials) - as PDF |
|
|
Detailed overview of key financial data (Evonik Financials) - as Excel |
|
|
Quarterly Statement Q1 2022 |
|
|
Investor Relations News Q1 2022 |
|
|
Analysts' consensus* (Vara Research)
|
PRELIMINARY FINANCIAL DATA 1st Quarter 2022
|
Document |
Link/PDF |
|
Ad-hoc Announcement preliminary results Q1 2022 |
|
|
Investor Relations News preliminary results Q1 2022 |
Capital Markets Day on May 11, 2022
Due to our Capital Markets Day shortly after the Q1 results, we have decided not to host a separate earnings conference call on May 6, 2022. You will have the opportunity to discuss the Q1 results during our Capital Markets Day, alongside with our strategy.
You can access further information here: Evonik's Capital Markets Day 2022
* The consensus is not controlled, changed or censored by Evonik Industries AG. Evonik Industries AG assumes no liability for the accuracy and completeness of these estimates and undertakes no obligation to update or revise such estimates and consensus data, even if they differ from Evonik Industries AG’s own forecasts or expectations. Evonik Industries AG is neither involved in the collection of the data, nor in the preparation of the consensus. This is done independently by Vara Research.